Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Memorial Sloan Kettering Cancer Center · Universitair Ziekenhuis Brussel · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,186
total citations
- FWCI
- 26.54
- Percentile
- 100%
- References
- 29
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Ipilimumab
- Adverse effect
- Clinical endpoint
- Internal medicine
- Melanoma
- Clinical trial
- Intention-to-treat analysis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.